Study Title
LINES: European Low and Intermediate Risk Neuroblastoma – A SIOPEN Study
Protocol ID
LINES
Condition/s
Neuroblastoma
Diagnosis Stage
New diagnosis
Location
NSW, VIC, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
Instituto de Investigacion Sanitaria La Fe
Links
Trial Status
Closed to Recruitment
Sites
John Hunter Children's Hospital
Monash Children's Hospital
Sydney Children's Hospital
Perth Children's Hospital
Monash Children's Hospital
Sydney Children's Hospital
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
90 days to 18 Years
International registry ID's
NCT01728155
| Study Title | LINES: European Low and Intermediate Risk Neuroblastoma – A SIOPEN Study |
|---|---|
| Protocol ID | LINES |
| Disease (Sub Disease) | Neuroblastoma |
| Diagnosis Stage | New diagnosis |
| Location | NSW / VIC / WA |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ |
| Collaborators | Instituto de Investigacion Sanitaria La Fe |
| Links | https://clinicaltrials.gov/ct2/show/NCT01728155 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 31/05/2019 |
| Sites | John Hunter Children's Hospital / Monash Children's Hospital / Sydney Children's Hospital / Perth Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | 90 days to 18 Years |
| International registry ID's | NCT01728155 |